TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $186,938,000 | +88.2% | 2,484,220 | -32.9% | 14.14% | +85.3% |
| Q1 2022 | $99,345,000 | -31.2% | 3,700,000 | +22.3% | 7.63% | -11.1% |
| Q4 2021 | $144,292,000 | -23.6% | 3,025,000 | +6.4% | 8.58% | +11.9% |
| Q3 2021 | $188,814,000 | -20.3% | 2,842,297 | -6.4% | 7.67% | -4.7% |
| Q2 2021 | $236,950,000 | -8.9% | 3,037,042 | +10.4% | 8.05% | +38.9% |
| Q1 2021 | $260,122,000 | -10.8% | 2,750,000 | +15.0% | 5.80% | -16.5% |
| Q4 2020 | $291,501,000 | +36.6% | 2,392,297 | -2.0% | 6.94% | -15.4% |
| Q3 2020 | $213,359,000 | +20.7% | 2,442,297 | -10.8% | 8.20% | +21.6% |
| Q2 2020 | $176,802,000 | +29.5% | 2,737,297 | -10.5% | 6.75% | +6.4% |
| Q1 2020 | $136,517,000 | -35.5% | 3,056,797 | -10.0% | 6.34% | -24.9% |
| Q4 2019 | $211,577,000 | +58.9% | 3,396,650 | -4.1% | 8.44% | +4.2% |
| Q3 2019 | $133,155,000 | +4.8% | 3,541,367 | +13.4% | 8.10% | +11.0% |
| Q2 2019 | $127,080,000 | – | 3,122,367 | – | 7.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |